170295 ⎘
Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOPLASMA PNEUMONIAE
#2BIOMARKERS FOR EARLY DIAGNOSIS AND DIFFERENTIATION OF MYCOBACTERIAL INFECTION
#3Compositions and Methods for the Detection of Mycoplasma
#4IMMUNOLOGICAL DETECTION METHOD AND KIT FOR MYCOPLASMA PNEUMONIAE
#5MYCOPLASMA PNEUMONIAE IMMUNOASSAY METHOD AND IMMUNOASSAY INSTRUMENT
#6Compounds for detecting and treating
#7METHOD FOR IMMUNOLOGICALLY DETECTING MYCOPLASMA PNEUMONIAE
#8PHAGE CONSTRUCTS FOR DETECTING BACTERIA IN A FLUID, MICROFLUIDIC DEVICES FOR USE WITH CONSTRUCTS, AND RELATED METHODS
#9Biomarkers for early diagnosis and differentiation of mycobacterial infection
#10INFECTION-RELATED PRETERM BIRTH DIAGNOSTIC METHOD
#11Ready to use porcine vaccine
#12immunological detection method and kit
#13PHAGE CONSTRUCTS FOR DETECTING BACTERIA IN A FLUID, MICROFLUIDIC DEVICES FOR USE WITH CONSTRUCTS, AND RELATED METHODS
#14Compositions and methods
#15Compounds for detecting and treating
#16Method for producing an isolated monoclonal antibody specifically binding to a glycolipid antigen of
#17immunological detection method and kit
#18POTENCY TEST FOR VACCINE FORMULATIONS
#19UREAPLASMA VACCINE AND ANTIBODIES
#20Biomarkers for early diagnosis and differentiation of mycobacterial infection
#21BIOMARKERS FOR EARLY DIAGNOSIS AND DIFFERENTIATION OF MYCOBACTERIAL INFECTION
#22Compositions and methods
#23TEST OBJECT DETECTION METHOD, AND IMMUNOASSAY INSTRUMENT AND MONOCLONAL ANTIBODY FOR SAME
#242,7-disubstituted cephalosporin derivatives as β-lactamase substrates and methods for their use for the diagnosis of tuberculosis
#25Immunological detection method and kit for
#26IMMUNOLOGICAL DETECTION METHOD AND KIT FOR MYCOPLASMA PNEUMONIAE
#27Mycoplasma pneumoniae detection reagent and application of same
#28Methods and compositions for detecting mycoplasma exposure
#29Potency test for vaccine formulations
#30Identification of mycoplasm contamination using Raman spectroscopy
#31Mycoplasma pneumoniae immunological detection method and kit
#32vaccine and antibodies
#33Biomarkers for early diagnosis and differentiation of mycobacterial infection
#34Tunable control of protein degradation in synthetic and endogenous bacterial systems
#35Rapid detection of analytes in liquid samples
#36Potency test for vaccine formulations
#37Potency test for vaccine formulations
#38LIVE ATTENUATED MYCOPLASMA STRAINS
#39VACCINE COMPOSITION FOR VACCINATING DOGS AGAINST CANINE INFECTIOUS RESPIRATORY DISEASE (CIRD)
#40Sensors for Measuring Contaminants
#41Glyceroglycolipid antigen of
#42LIVE ATTENUATED MYCOPLASMA STRAINS
#43VACCINE COMPOSITION FOR VACCINATING DOGS AGAINST CANINE INFECTIOUS RESPIRATORY DISEASE(CIRD)
#44Solid phase test device for sialidase assay
#45Substrates, sensors, and methods for assessing conditions in females
#46Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
#47Mycoplasma polypeptides
#48Saliva immunoassay for detection of exposure to infectious agents